Skip to main content

Table 1 Demographic, clinical, and laboratory information of patients

From: Upregulated miR-146a expression in peripheral blood mononuclear cells from rheumatoid arthritis patients

Subject

Sex

Age (years)

Medications

CRP (mg/l)

ESR (mm/hour)

RA Patients

     

   RA-1aa

Male

65

None

4.14b

9

   RA-1b

Male

65

MTX

11.8

18

   RA-2

Female

33

Etanercept, naproxen

25.7

18

   RA-3

Female

43

Etanercept

No data

No data

   RA-4

Female

45

None

98.4

84

   RA-5

Female

55

MTX

4.8

26

   RA-6

Female

73

None

2.1

30

   RA-7

Female

51

Hydroxychloroquine, MTX, prednisone

No data

15

   RA-8

Male

61

Prednisone, MTX, hydroxychloroquine, sulfasalazine

No data

1

   RA-9

Male

46

Methylprednisolone, MTX, etanercept

2

9

   RA-10

Female

32

Leflunomide

94.2

63

   RA-11

Female

50

Etanercept, MTX

No data

No data

   RA-12

Male

67

MTX, celecoxib, prednisone

0.6

11

   RA-13

Female

55

MTX

No data

17

   RA-14

Female

33

Hydroxychloroquine, ibuprofen

2.8

7

   RA-15

Female

55

None

168.2

88

   RA-16

Female

56

Prednisone, minocycline

No data

No data

Disease control individuals

     

   SLE1

Female

36

Hydroxychloroquine, prednisone, mycophenolate mofetil

  

   SjS1

Female

30

Hydroxychloroquine, mycophenolate mofetil

  

   SjS2

Male

21

Hydroxychloroquine

  

   SSc1

Female

57

Cyclosporine, hydroxychloroquine, prednisone, mycophenolate mofetil

  
  1. aSample collected from RA-1 before and after MTX treatment. bNormal value less than 0.8. The normal CRP is <4.9 mg/l, and the normal ESR is <20 mm/hour for females and <10 mm/hour for males. CRP, C-reactive protein; ESR, erythrocyte sedimentation rate; MTX, methotrexate; RA, rheumatoid arthritis; SLE, systemic lupus erythematosus; SjS, Sjögren's syndrome; SSc, scleroderma.